Literature DB >> 16105961

Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors.

Ken H Darzy1, Stephen M Shalet.   

Abstract

CONTEXT: For the first time, physiological cortisol secretion has been studied in ACTH-replete adult cancer survivors to explore any discrepancy between stimulated (during insulin-induced hypoglycemia) and spontaneous cortisol secretion and, in particular, the possible existence of ACTH neurosecretory dysfunction that might explain the excessive fatigue suffered by some cancer survivors. STUDY
SUBJECTS: Cortisol profiling at 20-min intervals over 24 h during the fed state was undertaken in 34 patients (10 females), aged 17-53.7 yr (median, 21.5 yr), 2-29 yr (median, 11.5 yr) after receiving conventional cranial irradiation for nonpituitary brain tumors or leukemia (n = 5) and in 33 age-, gender-, and body mass index-matched normal controls, of whom 23 patients and 17 controls were also profiled in the last 24 h of a 33-h fast.
RESULTS: The fed profile mean cortisol concentration (mean +/- sem) was significantly increased (by 14%) in the patients compared with that in normal subjects (213 +/- 6.9 vs. 187 +/- 6.7 nmol/liter; P = 0.009), with all individual values above the lowest seen in normal subjects. Multiparameter deconvolution analysis revealed a parallel increase (by 20%) in cortisol secretion rates (1.8 +/- 0.09 vs. 1.5 +/- 0.08 nmol/liter.min; P = 0.03) due to selective augmentation of the cortisol mass released per burst with no changes in burst frequency (12/24 h) or half-life. No significant differences were observed between males and females, after short-term fasting, or between female patients and normal females. Thus, in the light of total group comparisons, male patients had even higher values than normal males, and more so during fasting (mean cortisol and cortisol secretion increased by 20 and 29% in the fed state and by 41 and 32% in the fasting state, respectively; P < 0.05).
CONCLUSIONS: This study has demonstrated that radiation-induced ACTH neurosecretory dysfunction does not exist and, thus, resolved the clinical dilemma as to whether cortisol replacement should be considered in those patients with excessive fatigue and normal stimulated cortisol responses. On the contrary, cranial irradiation causes activation of the corticotrope-adrenal axis, and in the absence of ACTH deficiency, this activation is manifested by parallel increases in circulating cortisol levels and cortisol production rates without any change in cortisol half-life. The lack of cortisol increase in female patients may be attributed to the adverse effect of their higher body mass index on cortisol secretion or may reflect a genuine gender dichotomy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105961     DOI: 10.1210/jc.2005-0830

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Duration of suppression of adrenal steroids after glucocorticoid administration.

Authors:  John S Fuqua; Deborah Rotenstein; Peter A Lee
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-31

Review 2.  Hypopituitarism following radiotherapy.

Authors:  Ken H Darzy; Stephen M Shalet
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

3.  Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index.

Authors:  Johannes D Veldhuis; Ferdinand Roelfsema; Ali Iranmanesh; Bernard J Carroll; Daniel M Keenan; Steven M Pincus
Journal:  J Clin Endocrinol Metab       Date:  2009-09-15       Impact factor: 5.958

4.  Modified-release hydrocortisone to provide circadian cortisol profiles.

Authors:  Miguel Debono; Cyrus Ghobadi; Amin Rostami-Hodjegan; Hiep Huatan; Michael J Campbell; John Newell-Price; Ken Darzy; Deborah P Merke; Wiebke Arlt; Richard J Ross
Journal:  J Clin Endocrinol Metab       Date:  2009-02-17       Impact factor: 5.958

Review 5.  Radiation-induced hypopituitarism after cancer therapy: who, how and when to test.

Authors:  Ken H Darzy
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.